The Ewing's sarcoma fusion protein, EWS‐FLI, binds Runx2 and blocks osteoblast differentiation

Ewing's sarcomas are highly aggressive round cell tumors of bone and soft tissues that afflict children and young adults. The majority of these tumors harbor the t(11;22) translocation and express the fusion protein EWS‐FLI. Modern molecular profiling experiments indicate that Ewing's tumors originate from mesenchymal precursors in young individuals. EWS‐FLI alters the morphology of mesenchymal cells and prevents lineage specification; however, the molecular mechanisms for differentiation arrest are unclear. We recently showed that EWS‐FLI binds Runx2, a master regulator of osteoblast differentiation. In this report, we demonstrate that FLI sequences within EWS‐FLI are responsible for interactions with Runx2. EWS‐FLI blocks the expression of osteoblastic genes in a multipotent progenitor cell line that requires Runx2 to integrate bone morphogenic protein (Bmp)2 signaling while increasing proliferation and altering cell morphology. These results demonstrate that EWS‐FLI blocks the ability of Runx2 to induce osteoblast specification of a mesenchymal progenitor cell. Disrupting interactions between Runx2 and EWS‐FLI1 may promote differentiation of the tumor cell. J. Cell. Biochem. 111: 933–943, 2010. © 2010 Wiley‐Liss, Inc.

[1]  J. Schiffman,et al.  Recent advances in the molecular pathogenesis of Ewing's sarcoma , 2010, Oncogene.

[2]  J. Westendorf,et al.  TEThered to Runx: novel binding partners for runx factors. , 2010, Blood cells, molecules & diseases.

[3]  Vladimir N Uversky,et al.  Oncogenic Partnerships: EWS-FLI1 Protein Interactions Initiate Key Pathways of Ewing's Sarcoma , 2010, Clinical Cancer Research.

[4]  Robin L. Jones,et al.  Biological Rationale and Current Clinical Experience With Anti-Insulin-Like Growth Factor 1 Receptor Monoclonal Antibodies in Treating Sarcoma: Twenty Years From the Bench to the Bedside , 2010, Cancer journal.

[5]  P. Jedlicka.  Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. , 2010, International journal of clinical and experimental pathology.

[6]  J. Westendorf,et al.  Regulation of gene expression in osteoblasts , 2010, BioFactors.

[7]  J. Manley,et al.  The TET family of proteins: functions and roles in disease. , 2009, Journal of molecular cell biology.

[8]  S. Lessnick,et al.  EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma. , 2009, Cancer research.

[9]  Luke H. Hoeppner,et al.  Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation , 2009, Journal of cellular physiology.

[10]  Luke H. Hoeppner,et al.  Co‐activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors , 2009, Journal of cellular biochemistry.

[11]  A. Üren,et al.  Small molecule selected to disrupt oncogenic protein EWS-FLI1 interaction with RNA Helicase A inhibits Ewing's Sarcoma , 2009, Nature Medicine.

[12]  P. Meltzer,et al.  A Molecular Function Map of Ewing's Sarcoma , 2009, PloS one.

[13]  Nicolò Riggi,et al.  Identification of cancer stem cells in Ewing's sarcoma. , 2009, Cancer research.

[14]  M. Toyoda,et al.  EWS/ETS Regulates the Expression of the Dickkopf Family in Ewing Family Tumor Cells , 2009, PloS one.

[15]  H. Steen,et al.  Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development , 2008, Molecular and Cellular Biology.

[16]  A. Üren,et al.  A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing’s sarcoma , 2009 .

[17]  P. Lin,et al.  EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model. , 2008, Cancer Research.

[18]  G. Stein,et al.  Specific Residues of RUNX2 Are Obligatory for Formation of BMP2-Induced RUNX2-SMAD Complex to Promote Osteoblast Differentiation , 2008, Cells Tissues Organs.

[19]  G. Stein,et al.  p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation , 2008, Journal of cellular biochemistry.

[20]  S. K. Zaidi,et al.  Structural Coupling of Smad and Runx2 for Execution of the BMP2 Osteogenic Signal* , 2008, Journal of Biological Chemistry.

[21]  S. Lessnick,et al.  A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature , 2008, Cell cycle.

[22]  G. Gilkeson,et al.  Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. , 2008, Molecular immunology.

[23]  O. Delattre,et al.  Mesenchymal stem cell features of Ewing tumors. , 2007, Cancer cell.

[24]  L. Mccauley,et al.  Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP) , 2007, Cancer and Metastasis Reviews.

[25]  G. Hicks,et al.  TLS, EWS and TAF15: a model for transcriptional integration of gene expression. , 2006, Briefings in functional genomics & proteomics.

[26]  J. Davis,et al.  RUNX1 (AML‐1) and RUNX2 (AML‐3) cooperate with prostate‐derived Ets factor to activate transcription from the PSA upstream regulatory region , 2006, Journal of cellular biochemistry.

[27]  A. Trumpp,et al.  Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. , 2005, Cancer research.

[28]  G. Stein,et al.  Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription , 2005, Journal of cellular physiology.

[29]  H. Kovar.  Context matters: the hen or egg problem in Ewing's sarcoma. , 2005, Seminars in cancer biology.

[30]  DNA Microarrays Reveal Relationship of Ewing Family Tumors to Both Endothelial and Fetal Neural Crest-Derived Cells and Define Novel Targets , 2004, Cancer Research.

[31]  A. Seth,et al.  Ets2 transcription factor inhibits mineralization and affects target gene expression during osteoblast maturation. , 2004, In vivo.

[32]  O. Delattre,et al.  EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3 , 2004, Molecular and Cellular Biology.

[33]  S. Baker,et al.  Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. , 2003, Cancer research.

[34]  E. Olson,et al.  Alteration of Mesodermal Cell Differentiation by EWS/FLI-1, the Oncogene Implicated in Ewing's Sarcoma , 2003, Molecular and Cellular Biology.

[35]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[36]  R. Janknecht,et al.  The Ewing's sarcoma gene product functions as a transcriptional activator. , 2001, Cancer research.

[37]  Takahiro Ochi,et al.  Transcriptional regulation of osteopontin gene in vivo by PEBP2αA/CBFA1 and ETS1 in the skeletal tissues , 1998, Oncogene.

[38]  J. Lawrence,et al.  Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[40]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[41]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[42]  D. Yee,et al.  Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. , 1990, The Journal of clinical investigation.

[43]  J. Thiery,et al.  Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). , 1988, Cancer genetics and cytogenetics.

[44]  J. Ewing.  Diffuse endothelioma of bone , 1972 .

[45]  Gene fusion. , 1972, Brookhaven symposia in biology.